CPSF4-mediated regulation of alternative splicing of HMG20B facilitates the progression of triple-negative breast cancer
CPSF4 promotes TNBC progression by regulating AS of HMG20B. These findings contribute to the development of more useful prognostic, diagnostic and potentially therapeutic biomarkers for TNBC.
Authors
- Weiyang Lou (ORCID: https://orcid.org/0000-0002-4848-9891)
- Guansheng Zhong (ORCID: https://orcid.org/0000-0002-5803-6482)
- Xinli Zheng
- Qinyan Shen (ORCID: https://orcid.org/0000-0003-4869-477X)
- Hongjiang Lu
- Zhijun Dai (ORCID: https://orcid.org/0000-0001-5209-8626)
- Kun Yu (ORCID: https://orcid.org/0000-0002-7496-1889)
- Haidong Cui
- Bajin Wei
Institutions
- Wenzhou Medical University (CN)
- Zhejiang Provincial People's Hospital (CN)
- Dongyang People's Hospital (CN)
- Chinese People's Liberation Army (CN)
- Hangzhou Medical College (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1186/s12967-024-06004-x
- Citations
- 3
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province